Clover Health director reports 174,416 shares

Clover Health Investments, Corp. (CLOV) director Robert G. Torricelli reported 174,416 shares on September 22, 2026: 141,253 shares held directly and 33,163 shares underlying a time-based restricted stock unit award.

Rhea-AI Filing Summary

Clover Health Investments, Corp. (CLOV) director Robert G. Torricelli reported 174,416 shares on September 22, 2026: 141,253 shares held directly and 33,163 shares underlying a time-based restricted stock unit award. The RSUs vest in full on the first anniversary of April 1, 2026, subject to his continued service as a board member through that vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Torricelli Robert G

Role Director

Type	Security	Shares	Price	Value
holding	Class A Common Stock F1	--	--	--

Holdings After Transaction: Class A Common Stock — 174,416 shares (Direct)

Footnotes (1)

1. F1. Represents 33,163 shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") and 141,253 shares of Class A common stock held directly by the Reporting Person. The RSUs will vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

Key Figures

Reported shares: 174,416 shares Directly held shares: 141,253 shares Shares underlying RSUs: 33,163 shares

3 metrics

Reported shares 174,416 shares Reported on September 22, 2026.

Directly held shares 141,253 shares Shares held directly by Robert G. Torricelli.

Shares underlying RSUs 33,163 shares Underlying a time-based restricted stock unit award.

Key Terms

restricted stock unit award, vesting date, continued service

3 terms

restricted stock unit award financial

"time-based restricted stock unit award ("RSUs")"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

vesting date financial

"through such vesting date"

continued service financial

"subject to the Reporting Person's continued service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLOV shares does director Robert G. Torricelli report?

Robert G. Torricelli reported 174,416 shares, consisting of 141,253 shares held directly and 33,163 shares underlying time-based RSUs. The RSUs vest in full on the first anniversary of April 1, 2026, subject to his continued service as a board member through that vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 07:14 PM Accepted by SEC EDGAR 10/01/2026 - 07:14 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Torricelli Robert G

(Last) (First) (Middle)

1209 ORANGE STREET

(Street)

WILMINGTON DELAWARE 19801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/22/2026

3. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	174,416(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 33,163 shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") and 141,253 shares of Class A common stock held directly by the Reporting Person. The RSUs will vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

Remarks:

Ex. 24 - POA of Robert G. Torricelli

	/s/Peter J. Rivas as attorney-in-fact for Robert G. Torricelli	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)